Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prednisolone sodium phosphate 0.1% ear drops
1104010S0AABHBH
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.125% eye dps preserv free
1104010S0AAAXAX
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.125% eye drops
1104010S0AAAEAE
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.13% eye drops
1104010S0AAAQAQ
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.25% eye dps preserv free
1104010S0AAAKAK
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.25% eye drops
1104010S0AAAFAF
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.3% ear drops
1104010S0AABIBI
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Predsol 20mg/100ml retention enema
0105020E0BBABAB
|
Predsol (Rectal) | Prednisolone sodium phosphate | Gastro-Intestinal System | No data available |
|
Predsol-N ear/eye drops
1201010U0BBAAAA
|
Predsol-N | Prednisolone sodium phosphate | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.